Thrivent Financial For Lutherans Organogenesis Holdings Inc. Transaction History

Thrivent Financial For Lutherans

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$2.48 - $3.43 $1,359 - $1,879	-548 Reduced 0.75%	72,514 $195,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $34,219 - $70,074	10,898 Added 17.53%	73,062 $237,000
Q2 2022 Aug 16, 2022	BUY	$4.74 - $8.15 $51,419 - $88,411	10,848 Added 21.14%	62,164 $303,000
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $116 - $172	18 Added 0.04%	51,316 $391,000
Q4 2021 Feb 16, 2022	BUY	$9.02 - $13.5 $3,337 - $4,995	370 Added 0.73%	51,298 $474,000
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $137,771 - $172,641	10,049 Added 24.58%	50,928 $725,000
Q2 2021 Aug 19, 2021	BUY	$14.92 - $23.23 $609,914 - $949,619	40,879 New	40,879 $679,000

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $437M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.